News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 37–72
- Matches
- 223
- Sources here
- 19
- Companies here
- 8
Active search
223 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Pfizer (PFE) Agreed To A $44 Million Chantix Settlement
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Pfizer (NYSE:PFE) agreed to a US$44 million class action settlement related to its smoking cessation drug Chantix, addressing claims tied to product safety disclosures. …
Pfizer (PFE) Agrees To $44 Million Class Action Settlement
Pfizer has agreed to a US$44 million class action settlement concerning its Chantix smoking cessation drug, addressing allegations of undisclosed carcinogenic nitrosamines. This settlement is considered small relative to Pfizer's substantial revenue, fitting within existing regulatory and product liability risk frameworks rather than introducing …
Pfizer Inc. stock underperforms Tuesday when compared to competitors
Pfizer Inc. (PFE) stock fell by 1.59% on Tuesday, closing at $26.62, and underperformed the broader market, as the S&P 500 Index and Dow Jones Industrial Average also saw declines. This drop ended a seven-day winning streak for the stock. The article highlights Pfizer's …
Sharemaestro market context Price above Trend Line 52 weeks +22.2% · Next-week setup positive 56.8%OppFi Swings to $32 Million First-Half Loss Attributable
OppFi Inc. reported a significant increase in profitability for Q2 and the first half of 2026, alongside a substantial expansion in its Class A common share count. Despite a jump in operating income and pre-tax earnings, the threefold increase in Class A shares outstanding …
Pfizer vs AbbVie: What's the Better Dividend Stock for Investors in 2026?
This article compares AbbVie (ABBV) and Pfizer (PFE) as dividend stock options for investors in 2026. While AbbVie offers solid financials, strong free cash flow, and consistent dividend growth despite a lower current yield, Pfizer provides a much higher immediate yield but comes with …
Pfizer (PFE) Q2 2026 Earnings Call Transcript
Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026 at 11:00 a.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer - Albert Bourla Chief Financial Officer - David Denton Incoming Interim Chief Financial Officer and Executive Vice President - Cecile Guegan Chief Scientific …
Pfizer Inc. (PFE) vs. BioNTech SE (BNTX): Which Pharma Giant Is Better Positioned for the Post-COVID Era?
Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX), two companies forever linked by their historic COVID-19 vaccine partnership, reported Q2 2026 earnings alongside major strategic announcements. While the European Commission authorized their updated XFG-adapted COVID-19 vaccine on July 29, the two partners are traveling down …
KMG Fiduciary Partners LLC Acquires 39,875 Shares of Pfizer Inc. $PFE
KMG Fiduciary Partners LLC increased its stake in Pfizer Inc. by 26.4% in the second quarter, purchasing 39,875 shares to bring its total holdings to 190,888 shares valued at approximately $4.6 million. Despite this increased institutional interest, analyst sentiment remains cautious with an average …
OppFi Inc. Reports Q2 2026 Financials with Increased Assets and Reduced Debt in Form 10-Q Filing
OppFi Inc. has filed its Q2 2026 financial report on Form 10-Q with the U.S. Securities and Exchange Commission, detailing its performance for the fiscal quarter ending June 30, 2026. The report indicates an increase in the company's assets and a reduction in its …
OppFi Reports Second Quarter 2026 Results, Record Second Quarter Revenue
OppFi Inc. announced record second quarter revenue of $145.2 million, a 1.9% increase year-over-year, and a 36.0% increase in net income to $15.6 million for Q2 2026. The company is advancing its acquisition of BNCCORP, Inc. and BNC National Bank, preparing to launch a …
Pfizer, Inc. (PFE) Stock Price, News, Quote & History
This page provides a comprehensive overview of Pfizer, Inc. (PFE) stock information, including its real-time price, recent news, and performance data. The stock closed at $27.05, up 1.08%, with overnight trading activity showing a slight dip to $26.97. Recent news highlights Pfizer's Q2 earnings, …
Pfizer Inc (PFE-N) Press Releases
This page aggregates recent news and analyst opinions concerning Pfizer Inc. (PFE-N). It covers topics such as Pfizer's earnings, dividend outlook, advancements in COVID-19 booster strategies with BioNTech, and development of new weight-loss drugs. Various financial analysts and news outlets provide insights into the …
Pfizer Inc. stock outperforms competitors on strong trading day
Pfizer Inc. (PFE) shares rose 1.08% to $27.05 on Monday, extending its winning streak to seven consecutive days, despite a generally downbeat trading session for the broader market. The S&P 500 Index fell 0.06%, and the Dow Jones Industrial Average dropped 0.11%, highlighting Pfizer's …
Dudley & Shanley Inc. Makes New $3.97 Million Investment in Pfizer Inc. $PFE
Dudley & Shanley Inc. has acquired a new stake in Pfizer Inc. worth $3.97 million, purchasing 165,000 shares during the second quarter. This comes as Pfizer exceeded Q2 earnings expectations with adjusted EPS of $0.77 and revenue of $15.03 billion, while also issuing fiscal …
Direct Relief and The Pfizer Foundation Expand Support for Community Health Centers on the Front Lines of Infectious Disease Care
Direct Relief and The Pfizer Foundation have announced the third cohort of their Innovation Awards in Community Health, committing $4.5 million in grants over two years to 16 U.S. safety-net community health organizations. This initiative, now in its fifth year, supports efforts to strengthen …
Pfizer Rises Almost 7% Post Q2 Results: How to Play the Stock
Pfizer's stock rose almost 7% after its Q2 2026 results, beating earnings and revenue estimates, driven by non-COVID products despite declining COVID vaccine and treatment sales. The company raised the lower end of its 2026 revenue guidance but faces challenges from declining COVID product …
Sharemaestro market context Price above Trend Line 52 weeks +22.2% · Next-week setup positive 56.8%Pfizer explores localisation, supply-chain and healthcare partnerships across Middle East, Africa
Pfizer is actively seeking manufacturing, technology transfer, research, and capability-building partnerships across the Middle East and Africa. This initiative responds to the region's growing demand for drug security and innovative therapies, driven by demographic growth and increased healthcare investment. The company aims to strengthen …
Pfizer $44M settlement: How to know if you are included
Pfizer will pay $44 million to settle a class-action lawsuit concerning its smoking-cessation drug Chantix, which allegedly contained an undisclosed nitrosamine. The settlement covers U.S. individuals and third-party payors who purchased Chantix between September 29, 2015, and September 17, 2021. Claimants must file by …
Insider trades: Microsoft, Meta, Pfizer among notable names
[Meta European head office] Derick Hudson Insider transactions were seen across major firms this week, including Microsoft (MSFT [https://seekingalpha.com/symbol/MSFT]) and Meta (META [https://seekingalpha.com/symbol/META]). The following trades took place between August 3 and August 7. * Microsoft (MSFT [https://seekingalpha.com/symbol/MSFT]) saw two executives divest a small …
Insider trades: Microsoft, Meta, Pfizer among notable names (PFE:NYSE)
This article reports on notable insider trading activity that occurred between August 3 and August 7, 2026, involving several major companies. Executives at Microsoft and Meta divested portions of their holdings, while insider purchases were observed in companies like Pfizer, Taiwan Semiconductor, and Tilray …
Pfizer, Inc. (PFE) Stock Forecasts
Argus Senior Analyst David H. Toung has published a report on Pfizer Inc. (PFE), highlighting strong growth from the company's non-COVID products. The report provides a summary of Pfizer's position as a leading developer of pharmaceuticals and biotech drugs, including oncology, immunology, rare disease …
Sharemaestro market context Price above Trend Line 52 weeks +22.2% · Next-week setup positive 56.8%